CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini on Monday, April 29th. As previously communicated, the Immucor assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list are now available on our website.
On December 28, 2021, the FDA updated the emergency use authorization (EUA) for COVID-19 conva...
On September 23, 2019, the new CTS Laboratory Information System successfully implemented in Da...
We sincerely hope to see you at this year’s AABB Annual Meeting in Boston, MA on October 12-16...
On August 9, 2019, the new CTS Laboratory Information System was successfully implemented in St...
CTS will be revising some forms in use by clients on October 26, 2020. We do try to limit form chang...
At CTS, we understand the impact converting to the Ortho viral marker platform has on your operation...